What is the recommended treatment for a patient testing positive for syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Syphilis Treatment Recommendations

The recommended treatment for syphilis is benzathine penicillin G, with dosing dependent on the stage of infection: 2.4 million units IM as a single dose for primary, secondary, and early latent syphilis; or 7.2 million units total (administered as three doses of 2.4 million units IM at 1-week intervals) for late latent syphilis or syphilis of unknown duration. 1

Treatment by Stage

Primary, Secondary, and Early Latent Syphilis

  • First-line treatment: Benzathine penicillin G 2.4 million units IM in a single dose 1
  • Alternative for penicillin-allergic patients: Doxycycline 100 mg orally twice daily for 14 days 1, 2

Late Latent Syphilis or Syphilis of Unknown Duration

  • First-line treatment: Benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million units IM at 1-week intervals 1
  • Alternative for penicillin-allergic patients: Doxycycline 100 mg orally twice daily for 28 days 1, 2

Neurosyphilis

  • First-line treatment: Penicillin G aqueous 18-24 million units IV daily, administered as 3-4 million units every 4 hours for 10-14 days 1
  • Important note: Benzathine penicillin G is inadequate for treating neurosyphilis 3

Special Populations

Pregnant Women

  • Only recommended treatment: Penicillin (appropriate to stage)
  • Penicillin is the only proven effective treatment for syphilis during pregnancy 1
  • If allergic to penicillin, desensitization is required 1

HIV-Infected Patients

  • Same treatment regimens as HIV-negative patients but with closer follow-up 1

Treatment Monitoring and Follow-up

Serologic Testing

  • Quantitative nontreponemal tests (RPR or VDRL) should be repeated at 6,12, and 24 months 1
  • Treatment success indicators:
    • Primary/secondary syphilis: Fourfold decline in titers within 6 months 1
    • Latent/late syphilis: Fourfold decline in titers within 12-24 months 1, 4

Treatment Failure

Consider retreatment if:

  • Titers increase fourfold
  • Initially high titer fails to decline
  • Signs or symptoms attributable to syphilis develop 1

Partner Management

  • All sexual partners should be evaluated clinically and serologically 1
  • Partners exposed within 90 days: Treat presumptively even if seronegative
  • Partners exposed >90 days before diagnosis: Treat based on clinical and serological evaluation 1

Important Clinical Considerations

Penicillin Allergy Management

  • For non-pregnant patients with penicillin allergy, doxycycline is the preferred alternative 1, 2
  • For pregnant patients with penicillin allergy, desensitization is required 1

CSF Examination Indications

Perform CSF examination before treatment if:

  • Neurologic or ophthalmic signs/symptoms present
  • Evidence of active tertiary syphilis
  • Treatment failure
  • HIV infection 1

Current Challenges

  • Benzathine penicillin G shortages have been reported, potentially complicating treatment 5
  • If BPG is unavailable, alternative regimens may be necessary, but efforts should be made to secure BPG, especially for pregnant women 5

Cautions and Pitfalls

  • Neurosyphilis requires IV penicillin treatment; benzathine penicillin G is ineffective for neurosyphilis 3
  • Approximately 15% of patients may not meet standard criteria for serological cure 12 months after adequate treatment, requiring ongoing monitoring 1
  • When administering benzathine penicillin G, either single or divided doses are equally well tolerated 6

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.